PCSK9 and endothelial dysfunction: This study shows that in nondialysis CKD patients, plasma levels of PCSK9 are directly associated with the endothelial dysfunction biomarker sICAM-1 and with Lp(a), an established risk factor for myocardial infraction and cardiovascular death in CKD patients [35].